CapitalCell

LentiStem Biotech

Carlos Blanco Benítez, 22 April, 2021, 0

LentiStem Biotech "Next-generation of gene-based therapies" Cancer therapeutics Prototyping, preclinical Spain IP Type Status Time Countries Link Coverage Patent Approved...

+

MJN-neuro

Marc Sastre Capital Cell, 21 April, 2021, 0

MJN-neuro A social impact company to improve the quality of life for people with epilepsy and other diseases Medical...

+

Nexkin medical

Marc Sastre Capital Cell, 16 April, 2021, 0

Nexkin medical Digital allergy testing Medical Device Development, market readiness, clinical trial Spain 800.000€ IP Type Status Time Countries Link...

+

SINCROLAB

Marc Sastre Capital Cell, 12 April, 2021, 0

SINCROLAB Developing AI for Neurological Diseases Treatment through mobile devices Digital Health Development, market readiness, clinical trial SPAIN 1.000.000€ IP...

+

NUUBO

Marc Sastre Capital Cell, 31 March, 2021, 0

NUUBO Disruptive wireless, textile-based wearable ECG technology for better arrhythmia diagnosis Medical Device Sales, Licensing Phases SPAIN, USA 2.000.000€ IP...

+

Deneb Medical S.L.

Marc Sastre Capital Cell, 30 March, 2021, 0

Deneb Medical S.L. Deneb is a start-up that is developing a surgical platform that will change the standard of care...

+

Biointaxis S.L.

Marc Sastre Capital Cell, 25 March, 2021, 0

Biointaxis S.L. A spin-off biotech company developing a state-of-the-art gene therapy for Friedreich's ataxia Biotech Prototyping, preclinical Spain 1.100.000€ IP...

+

BITAC

Marc Sastre Capital Cell, 22 March, 2021, 0

BITAC SaaS platform allowing automatic coding of clinical information into international standard terminologies. Digital Health Profit, dividends Spain 300.000€ You...